Bio-Sulpiride 200 mg Tablets
PDF Leaflet Revision Date: 30 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Management of schizophrenia and prevention of relapses.
Dosage (summary)
Initial: 200-800 mg/day in divided doses; Maintenance: 600-800 mg/day.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Dopaminergic anti-Parkinson medicines
- Alcohol
- Antihypertensive medicines
Contraindications
- Hypersensitivity to sulpiride
- Phaeochromocytoma
- Bone marrow depression
- Porphyria
- Prolactin-dependent tumors
Common side effects
- Sedation
- Extrapyramidal symptoms
- Hyperprolactinaemia
- Weight gain
Counselling Points
- Avoid alcohol during treatment.
- Monitor for signs of blood dyscrasia.
- Do not drive or operate machinery if drowsy.
Serious warnings
- Neuroleptic malignant syndrome
- QT prolongation
- Increased mortality in elderly with dementia
Important Disclaimer
The Bio-Sulpiride 200 mg Tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
